News Feature in 2015

A wave of experiments is probing the root of quantum weirdness.

Antibodies are the workhorses of biological experiments, but they are littering the field with false findings. A few evangelists are pushing for change.

A special issue explores the enormous potential and major challenges for research in south Asia's superpower.

Highs and lows in the country’s research landscape.

K. VijayRaghavan is determined to cut through red tape and build up biological science in India.

Despite great strides in some areas of research and development, the nation still has a long way to go.

When and how to exit research has become a charged issue in science.

After years of second-class status in research partnerships, African scientists are calling for change.

Four years after revolutions shook governments in North Africa and the Middle East, scientists face an uncertain future.

The fall out from the STAP case is still being felt across Japan.

Chemists hope to break China's monopoly on rare-earth elements by finding cheap, efficient ways to extract them from ore.

Forensic geologist Lorna Dawson has pioneered methods to help convict criminals using the dirt from their shoes.

Thirty years of pursuit have failed to yield a drug to take on one of the deadliest families of cancer-causing proteins. Now some researchers are taking another shot.

Key voices from the project reveal the twists and turns of the space telescope’s 25-year career.

Swiss-cheese-like materials called metal–organic frameworks have long promised to improve gas storage, separation and catalysis. Now they are coming of age.

There is a growing number of postdocs and few places in academia for them to go. But change could be on the way.

Brazil has waged a successful war on tropical deforestation, and other countries are trying to follow its lead. But victory remains fragile.

Transfusions are one of the most overused treatments in modern medicine, at a cost of billions of dollars. Researchers are working out how to cut back.

US funding agencies are turning to a Silicon Valley entrepreneur to focus fledgling biomedical companies on success — even when that means making a scientific course correction.

Short-sightedness is reaching epidemic proportions. Some scientists think they have found a reason why.